ASX:ALS 19 May 2026

ALS Ltd dips before joining S&P/ASX 50, down 0.3% to A$23.36
·

ALS Ltd dips before joining S&P/ASX 50, down 0.3% to A$23.36

ALS Ltd closed at A$23.36 on Thursday, down 6 cents. Shares bounced off a session low of A$22.83 to end at the day’s high. The testing firm is set to join the S&P/ASX 50 before Monday, taking the spot of Pro Medicus, the medical-imaging software group. That shift is key for index-trackers, since these funds mimic the benchmark and usually swap holdings when the index lineup changes. ALS also has its on-market share purchase for the dividend reinvestment plan, or DRP, open now, so trading in the short term could show fund activity more than any new take on earnings.
June 19, 2026
ALS Shares Drop Despite Record Profit as Tuesday Open Looms
····

ALS Shares Drop Despite Record Profit as Tuesday Open Looms

ALS Ltd is set to face another test at Tuesday’s ASX open after shares slipped 1.7% Monday. This drop came even as the laboratory-testing company posted record annual earnings and boosted its dividend. Shares ended at A$21.83, trading in a range from A$21.32 to A$22.90 for the day. Market focus is on ALS after it posted profit growth that met what investors wanted, but the share price is weighing if next year will keep pace. ALS reported revenue up 10.7% to A$3.32 billion for the year to March 31. Underlying NPAT — net profit after tax before significant items — climbed 25.8% to A$381.2 million, the company said.
May 19, 2026